IRIS International Reports Granting of Inducement Awards
22 juil. 2011 14h35 HE
|
IRIS International, Inc.
CHATSWORTH, Calif., July 22, 2011 (GLOBE NEWSWIRE) -- IRIS International, Inc. (Nasdaq:IRIS), a leading manufacturer of automated in-vitro diagnostics systems and consumables for use in hospitals and...
IRIS to Present at Jefferies 2011 Global Healthcare Conference on June 9, 2011
26 mai 2011 12h57 HE
|
IRIS International, Inc.
CHATSWORTH, Calif., May 26, 2011 (GLOBE NEWSWIRE) -- IRIS International, Inc. (Nasdaq:IRIS), a leading manufacturer of automated in-vitro diagnostics systems and consumables for use in hospitals and...
IRIS International's NADiA(R) ProsVue(TM) Prognostic Prostate Cancer Test Data From Multi-Center Clinical Study Presented at American Urological Association (AUA) 2011 Annual Meeting
23 mai 2011 07h00 HE
|
IRIS International, Inc.
CHATSWORTH, Calif., May 23, 2011 (GLOBE NEWSWIRE) -- IRIS International, Inc. (Nasdaq:IRIS), announced today that a poster of the results of a multi-center clinical study utilizing its proprietary...
IRIS to Hold 2011 Annual Meeting of Stockholders on Friday, May 20, 2011
17 mai 2011 07h00 HE
|
IRIS International, Inc.
CHATSWORTH, Calif., May 17, 2011 (GLOBE NEWSWIRE) -- IRIS International, Inc. (Nasdaq:IRIS), today announced that it will hold its 2011 Annual Meeting of Stockholders on Friday, May 20, 2011 at 10:00...
IRIS International to Present at 7th Annual Spring Growth Stock Conference Hosted by Security Research Associates, Inc.
09 mai 2011 07h00 HE
|
IRIS International, Inc.
CHATSWORTH, Calif., May 9, 2011 (GLOBE NEWSWIRE) -- IRIS International, Inc. (Nasdaq:IRIS), a leading manufacturer of automated in-vitro diagnostics systems and consumables for use in hospitals and...
IRIS International Reports Record First Quarter Revenue Bolstered by Strong Recurring Consumables and Service Revenue
04 mai 2011 16h01 HE
|
IRIS International, Inc.
CHATSWORTH, Calif., May 4, 2011 (GLOBE NEWSWIRE) -- IRIS International, Inc. (Nasdaq:IRIS), today announced record revenue of $26.9 million for the first quarter ended March 31, 2011, a 4% increase...
IRIS to Release First Quarter Financial Results and Host Conference Call and Webcast on Wednesday, May 4, 2011
18 avr. 2011 07h00 HE
|
IRIS International, Inc.
CHATSWORTH, Calif., April 18, 2011 (GLOBE NEWSWIRE) -- IRIS International, Inc. (Nasdaq:IRIS), will release its 2011 first quarter financial results after the close of trading on Wednesday, May 4,...
IRIS International Begins U.S. Commercial Shipments of iChem(R)VELOCITY(TM) and iRICELL(R) Urinalysis Workstation in March Following Recent FDA 510(k) Clearance
06 avr. 2011 07h00 HE
|
IRIS International, Inc.
CHATSWORTH, Calif., April 6, 2011 (GLOBE NEWSWIRE) -- IRIS International, Inc. (Nasdaq:IRIS), a leading manufacturer of automated in-vitro diagnostics systems and consumables for use in hospitals and...
IRIS International and Fujirebio Inc. Sign Joint Development Agreement for IRIS's 3GEMS(TM) Hematology Analyzer Product Line in Japan
04 avr. 2011 07h00 HE
|
IRIS International, Inc.
CHATSWORTH, Calif., April 4, 2011 (GLOBE NEWSWIRE) -- IRIS INTERNATIONAL, INC. (Nasdaq:IRIS), a leading manufacturer of automated in-vitro diagnostics systems and consumables, and a provider of high...
IRIS International Receives FDA 510(k) Clearance for Its iChem(R)VELOCITY(TM) Automated Urine Chemistry Analyzer and iRICELL(R) Urinalysis Workstation
24 mars 2011 14h34 HE
|
IRIS International, Inc.
CHATSWORTH, Calif., March 24, 2011 (GLOBE NEWSWIRE) -- IRIS International, Inc. (Nasdaq:IRIS), a leading manufacturer of automated in-vitro diagnostics systems and consumables for use in hospitals and...